申请人:Porter John Robert
公开号:US06953798B1
公开(公告)日:2005-10-11
Alkanoic acid derivatives of formula (1) are described:
Ar
1
(Alk
a
)
r
L
1
Ar
2
CH(R
1
)C(R
a
)(R
a′
)R (1)
Ar
1
is an optionally substituted aromatic or heteroarotic group;
L
1
is a covalent bond or a linker atom or group;
Ar
2
is an optionally substituted phenylene or nitrogen-containing six-membered heteroarylene group;
R is a carboxylic acid (—CO
2
H) or a derivative thereof;
and the salts, solvates, hydrates and N-oxides thereof.
The compounds are able to inhibit the binding of α4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
公式(1)中描述了Alkanoic酸衍生物:Ar1(Alka)rL1Ar2CH(R1)C(Ra)(Ra′)R (1)Ar1是一个可选择取代的芳香族或杂环芳基;L1是一个共价键或连接原子或基团;Ar2是一个可选择取代的苯基或含氮的六元杂环芳基;R是一个羧酸(—CO2H)或其衍生物;以及它们的盐、溶剂合物、水合物和N-氧化物。这些化合物能够抑制α4整合素与其配体的结合,并用于预防和治疗免疫或炎症性疾病。